American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
The expanded ownership is expected to improve access to Cialis for millions of men in Asia affected by ED and BPH
The Japanese Patent Office has issued a favorable Appeal Decision granting a patent for the use of REQORSA Gene Therapy in combination with PD-L1 antibodies to treat cancer
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
The pharmaceutical segment led growth, generating Rs. 337 crore in revenue, while the crop protection business contributed Rs. 157 crore
This deal marks a major step for Alteogen as it pushes its Hybrozyme platform deeper into the oncology market
GCCL aims to leverage the partnership to expand strategic relationships with global CROs
The researchers removed a chemical group commonly used in previous NK1R drugs and replaced it with a novel molecular scaffold
Nxera will take full responsibility for regulatory approvals, clinical development where required, manufacturing and commercialization in the licensed territories
Subscribe To Our Newsletter & Stay Updated
